BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Nymox Pharmaceutical Reports Successful New Long-Term Fexapotide Placebo Crossover Study Results: Major Reduction In Incidence Of Surgery

  August 24, 2016

   · 

  4 min read
• Business

  BioConsortia Welcomes Top Scientists To Its Science Advisory Board

  August 24, 2016

   · 

  1 min read
• Business

  Rodrigo Cifuentes Joins Pace International As Vice President Of Marketing And Business Development

  August 24, 2016

   · 

  3 min read
• Genetown

  Visterra, Inc. To Present New Clinical Results Of VIS410 At The Options IX For The Control Of Influenza Conference

  August 24, 2016

   · 

  1 min read
• Business

  Frenova Renal Research Adds New Talent And Continues Geographic Expansion

  August 24, 2016

   · 

  1 min read
• Business

  Luye Medical Commits $300 Million To Chongqing Hospital Venture

  August 24, 2016

   · 

  1 min read
• Pharm Country

  4 Must-See Biotech Stock Charts

  August 24, 2016

   · 

  1 min read
• Business

  NeuroVive’s COO Resigns

  August 24, 2016

   · 

  2 min read
• Pharm Country

  Data from Phase 3b ENSURE-AF Study Investigating Once-Daily SAVAYSA (Edoxaban) In Patients With Atrial Fibrillation Undergoing Cardioversion Among 13 Daiichi Sankyo Clinical Presentations At European Society of Cardiology Congress 2016

  August 24, 2016

   · 

  17 min read
• Drug Development

  RegeneRx Biopharmaceuticals, Inc. Joint Venture To Begin Second Phase 3 Study Of RGN-259 For Dry Eye Syndrome In 3rd Quarter

  August 24, 2016

   · 

  5 min read